The WHO Consolidated Guidelines on Tuberculosis (TB), Module 4: Treatment-Drug-
Resistant Tuberculosis Treatment 2022 update informs health care professionals in Member …

Page 1 WHO Module 4: Treatment Drug-susceptible tuberculosis treatment operational
handbook on tuberculosis World Health Organization Page 2 WHO operationa handbook …

Introduction Global migration has increased in recent decades due to war, conflict,
persecutions, and natural disasters, but also secondary to increased opportunities related to …

Vaccination is an excellent approach to stimulating the host immune response and reducing
human morbidity and mortality against microbial infections, such as tuberculosis (TB) …

Background Tuberculosis (TB) is a major public health challenge in Ethiopia. TB treatment
outcomes were suboptimal compared to the expected target of the national TB control …

Rifampicin is an important agent for tuberculosis treatment; however, it is often discontinued
because of adverse reactions. The treatment regimen then can be administered as that for …

Scope The current tools for tuberculosis (TB) treatment monitoring, smear microscopy and
culture, cannot accurately predict poor treatment outcomes. Research into new TB treatment …

Background Tuberculosis (TB) is a complex disease associated with other medical
conditions, that may affect disease severity. This study aimed to investigate the impact of …

Operational handbook on tuberculosis. Module 4: Treatment of drug-resistant tuberculosis
treatment, is a derivative product arising from the guideline on the same topic. This …

Objectives To describe long-term treatment outcomes in patients with multi-drug-
resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) and validate established outcome …